Interpace Biosciences, Inc. (IDXG)
USD 1.18
(-8.01%)
USD 1.18
(-8.01%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 7.69 Million USD | -31.69% |
| 2022 | 11.26 Million USD | 8.28% |
| 2021 | 10.4 Million USD | 427.48% |
| 2020 | 1.97 Million USD | -58.7% |
| 2019 | 4.77 Million USD | 178.69% |
| 2018 | -6.06 Million USD | 60.08% |
| 2017 | -15.19 Million USD | -308.03% |
| 2016 | 7.3 Million USD | 8297.7% |
| 2015 | 87 Thousand USD | -97.85% |
| 2014 | 4.04 Million USD | 108.86% |
| 2013 | -45.63 Million USD | 13.53% |
| 2012 | -52.78 Million USD | 17.96% |
| 2011 | -64.33 Million USD | -2.59% |
| 2010 | -62.71 Million USD | 13.46% |
| 2009 | -72.46 Million USD | 19.55% |
| 2008 | -90.07 Million USD | 9.19% |
| 2007 | -99.18 Million USD | -119.33% |
| 2006 | -45.22 Million USD | 50.21% |
| 2005 | -90.82 Million USD | 5.75% |
| 2004 | -96.36 Million USD | 14.94% |
| 2003 | -113.28 Million USD | -69.52% |
| 2002 | -66.82 Million USD | 58.24% |
| 2001 | -160.04 Million USD | -46.83% |
| 2000 | -109 Million USD | -88.58% |
| 1999 | -57.8 Million USD | -2.85% |
| 1998 | -56.2 Million USD | -885.96% |
| 1997 | -5.7 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 7.76 Million USD | 0.9% |
| 2024 Q2 | 6.37 Million USD | -17.94% |
| 2023 FY | 7.69 Million USD | -31.69% |
| 2023 Q1 | 10.02 Million USD | -10.98% |
| 2023 Q3 | 8.5 Million USD | -13.38% |
| 2023 Q2 | 9.81 Million USD | -2.08% |
| 2023 Q4 | 7.69 Million USD | -9.51% |
| 2022 FY | 11.26 Million USD | 8.28% |
| 2022 Q2 | 14.13 Million USD | 23.14% |
| 2022 Q1 | 11.48 Million USD | 10.38% |
| 2022 Q3 | 7.03 Million USD | -50.27% |
| 2022 Q4 | 11.26 Million USD | 60.19% |
| 2021 Q4 | 10.4 Million USD | 14.98% |
| 2021 Q2 | 8.05 Million USD | 21.59% |
| 2021 Q3 | 9.04 Million USD | 12.34% |
| 2021 FY | 10.4 Million USD | 427.48% |
| 2021 Q1 | 6.62 Million USD | 235.85% |
| 2020 Q4 | 1.97 Million USD | 720.13% |
| 2020 Q3 | -318 Thousand USD | 95.07% |
| 2020 FY | 1.97 Million USD | -58.7% |
| 2020 Q1 | -9.37 Million USD | -296.34% |
| 2020 Q2 | -6.44 Million USD | 31.25% |
| 2019 Q2 | -1.89 Million USD | 71.67% |
| 2019 Q4 | 4.77 Million USD | -13.96% |
| 2019 Q1 | -6.69 Million USD | -10.4% |
| 2019 Q3 | 5.55 Million USD | 392.41% |
| 2019 FY | 4.77 Million USD | 178.69% |
| 2018 Q3 | -8 Million USD | 20.65% |
| 2018 FY | -6.06 Million USD | 60.08% |
| 2018 Q1 | -12.64 Million USD | 16.8% |
| 2018 Q2 | -10.08 Million USD | 20.25% |
| 2018 Q4 | -6.06 Million USD | 24.17% |
| 2017 FY | -15.19 Million USD | -308.03% |
| 2017 Q1 | -2.76 Million USD | -137.8% |
| 2017 Q3 | -11.7 Million USD | 17.96% |
| 2017 Q2 | -14.26 Million USD | -416.47% |
| 2017 Q4 | -15.19 Million USD | -29.87% |
| 2016 Q4 | 7.3 Million USD | -0.33% |
| 2016 FY | 7.3 Million USD | 8297.7% |
| 2016 Q3 | 7.33 Million USD | 27.01% |
| 2016 Q2 | 5.77 Million USD | 35.47% |
| 2016 Q1 | 4.26 Million USD | 4796.55% |
| 2015 Q2 | 13.29 Million USD | 28.54% |
| 2015 Q3 | 18.95 Million USD | 42.56% |
| 2015 Q4 | 87 Thousand USD | -99.54% |
| 2015 FY | 87 Thousand USD | -97.85% |
| 2015 Q1 | 10.34 Million USD | 155.87% |
| 2014 Q1 | -37.87 Million USD | 17.01% |
| 2014 Q4 | 4.04 Million USD | 114.97% |
| 2014 FY | 4.04 Million USD | 108.86% |
| 2014 Q3 | -27 Million USD | 24.19% |
| 2014 Q2 | -35.62 Million USD | 5.96% |
| 2013 Q1 | -53.33 Million USD | -1.04% |
| 2013 FY | -45.63 Million USD | 13.53% |
| 2013 Q2 | -51.02 Million USD | 4.33% |
| 2013 Q4 | -45.63 Million USD | 8.04% |
| 2013 Q3 | -49.62 Million USD | 2.74% |
| 2012 Q4 | -52.78 Million USD | 12.8% |
| 2012 FY | -52.78 Million USD | 17.96% |
| 2012 Q3 | -60.52 Million USD | -6.31% |
| 2012 Q2 | -56.93 Million USD | 7.97% |
| 2012 Q1 | -61.87 Million USD | 3.83% |
| 2011 Q4 | -64.33 Million USD | 1.7% |
| 2011 Q3 | -65.45 Million USD | -2.24% |
| 2011 Q1 | -64.32 Million USD | -2.58% |
| 2011 Q2 | -64.02 Million USD | 0.48% |
| 2011 FY | -64.33 Million USD | -2.59% |
| 2010 FY | -62.71 Million USD | 13.46% |
| 2010 Q4 | -62.71 Million USD | 24.77% |
| 2010 Q2 | -80.89 Million USD | -11.28% |
| 2010 Q3 | -83.35 Million USD | -3.05% |
| 2010 Q1 | -72.69 Million USD | -0.31% |
| 2009 Q1 | -80.93 Million USD | 10.15% |
| 2009 Q3 | -70.55 Million USD | 7.42% |
| 2009 Q4 | -72.46 Million USD | -2.71% |
| 2009 FY | -72.46 Million USD | 19.55% |
| 2009 Q2 | -76.2 Million USD | 5.84% |
| 2008 Q4 | -90.07 Million USD | 4.49% |
| 2008 Q2 | -95.96 Million USD | 5.48% |
| 2008 FY | -90.07 Million USD | 9.19% |
| 2008 Q1 | -101.52 Million USD | -2.36% |
| 2008 Q3 | -94.31 Million USD | 1.72% |
| 2007 Q1 | -54.86 Million USD | -21.33% |
| 2007 Q4 | -99.18 Million USD | 10.5% |
| 2007 Q3 | -110.82 Million USD | -22.05% |
| 2007 Q2 | -90.8 Million USD | -65.49% |
| 2007 FY | -99.18 Million USD | -119.33% |
| 2006 Q3 | -38.97 Million USD | 30.77% |
| 2006 FY | -45.22 Million USD | 50.21% |
| 2006 Q2 | -56.3 Million USD | 28.07% |
| 2006 Q4 | -45.22 Million USD | -16.02% |
| 2006 Q1 | -78.26 Million USD | 13.83% |
| 2005 FY | -90.82 Million USD | 5.75% |
| 2005 Q4 | -90.82 Million USD | 3.14% |
| 2005 Q3 | -93.77 Million USD | 3.06% |
| 2005 Q2 | -96.73 Million USD | -17.45% |
| 2005 Q1 | -82.36 Million USD | 14.53% |
| 2004 Q4 | -96.36 Million USD | -24.69% |
| 2004 Q3 | -77.28 Million USD | 15.58% |
| 2004 Q2 | -91.54 Million USD | -22.54% |
| 2004 Q1 | -74.7 Million USD | 34.06% |
| 2004 FY | -96.36 Million USD | 14.94% |
| 2003 Q4 | -113.28 Million USD | -14.29% |
| 2003 Q2 | -66.48 Million USD | -3.47% |
| 2003 FY | -113.28 Million USD | -69.52% |
| 2003 Q1 | -64.25 Million USD | 3.85% |
| 2003 Q3 | -99.12 Million USD | -49.09% |
| 2002 Q2 | -68.92 Million USD | 53.28% |
| 2002 Q1 | -147.52 Million USD | 7.82% |
| 2002 FY | -66.82 Million USD | 58.24% |
| 2002 Q4 | -66.82 Million USD | 20.39% |
| 2002 Q3 | -83.94 Million USD | -21.79% |
| 2001 Q2 | -77.4 Million USD | 29.47% |
| 2001 FY | -160.04 Million USD | -46.83% |
| 2001 Q4 | -160.04 Million USD | -167.01% |
| 2001 Q1 | -109.75 Million USD | -0.7% |
| 2001 Q3 | -59.93 Million USD | 22.57% |
| 2000 Q4 | -109 Million USD | 8.12% |
| 2000 FY | -109 Million USD | -88.58% |
| 2000 Q1 | -115.84 Million USD | -100.43% |
| 2000 Q2 | -111.83 Million USD | 3.47% |
| 2000 Q3 | -118.63 Million USD | -6.08% |
| 1999 Q4 | -57.8 Million USD | 0.86% |
| 1999 Q3 | -58.3 Million USD | 12.59% |
| 1999 FY | -57.8 Million USD | -2.85% |
| 1999 Q2 | -66.7 Million USD | -3.25% |
| 1999 Q1 | -64.6 Million USD | -14.95% |
| 1998 Q1 | -10.6 Million USD | -85.96% |
| 1998 Q3 | -54.1 Million USD | -4.24% |
| 1998 Q4 | -56.2 Million USD | -3.88% |
| 1998 Q2 | -51.9 Million USD | -389.62% |
| 1998 FY | -56.2 Million USD | -885.96% |
| 1997 FY | -5.7 Million USD | 0.0% |
| 1997 Q4 | -5.7 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | -248.776% |
| Arrayit Corporation | 1.05 Million USD | -628.888% |
| Atlantic International Corp. | 236.49 Thousand USD | -3153.332% |
| Biocept, Inc. | -788 Thousand USD | 1076.396% |
| Bioqual, Inc. | -12 Million USD | 164.079% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | -33736.141% |
| DermTech, Inc. | 17.65 Million USD | 56.415% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 101.344% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 204.298% |
| iMD Companies, Inc. | 1.11 Million USD | -589.48% |
| IDenta Corp. | 524.85 Thousand USD | -1365.937% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | 28647.047% |
| InVitro International | -313.14 Thousand USD | 2557.032% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | -391.342% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | 1079202.384% |
| Medical Imaging Corp. | 3.79 Million USD | -102.958% |
| NovelStem International Corp. | 3.52 Million USD | -118.484% |
| Optigenex Inc. | 8.93 Million USD | 13.879% |
| PharmChem, Inc. | -1.49 Million USD | 614.851% |
| Proteome Sciences plc | 14.57 Million USD | 47.205% |
| Response Genetics, Inc | -13.08 Million USD | 158.796% |
| Rennova Health, Inc. | 14.82 Million USD | 48.118% |
| RushNet, Inc. | 4.8 Million USD | -60.263% |
| ScreenPro Security Inc. | 135.58 Thousand USD | -5574.502% |
| Stella Diagnostics Inc. | 6.19 Million USD | -24.236% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | -331.182% |
| Todos Medical Ltd. | 38.31 Million USD | 79.919% |